YDR179W-A Antibody

What is YDR179W-A and why is it significant in yeast research?

YDR179W-A is an uncharacterized protein in Saccharomyces cerevisiae (Baker's yeast) with potential functional significance in yeast cellular processes. Research into this protein contributes to our understanding of yeast genomics and proteomics, particularly in relation to uncharacterized open reading frames (ORFs). The protein is encoded by the YDR179W-A gene, which has been identified through genomic sequencing but remains functionally underexplored. Studying this protein using specific antibodies allows researchers to investigate its expression patterns, subcellular localization, and potential interaction partners, which may reveal its biological role in yeast cellular physiology.

What are the optimal storage conditions for maintaining YDR179W-A antibody activity?

For maximum stability and performance of YDR179W-A antibody:

Upon receipt, centrifuge the vial briefly to collect any liquid that may have become entrapped in the cap during shipment. Store in small aliquots to minimize freeze-thaw cycles, as each cycle may reduce antibody activity by approximately 10-15%. The antibody formulation containing 50% glycerol helps maintain stability during freeze-thaw processes .

What specific applications has YDR179W-A antibody been validated for?

The YDR179W-A polyclonal antibody has been specifically tested and validated for:

• Western Blot (WB) analysis for protein detection and quantification

• Enzyme-Linked Immunosorbent Assay (ELISA) for quantitative antigen detection

When using this antibody for Western blot applications, researchers should ensure proper identification of the antigen by including appropriate positive and negative controls. For optimal results in initial experiments, a titration of antibody concentrations is recommended to determine the optimal working dilution for your specific experimental conditions .

How should I validate the specificity of YDR179W-A antibody in my yeast strain?

Comprehensive validation of YDR179W-A antibody specificity should include:

• Genetic validation: Compare wild-type strains with YDR179W-A deletion mutants to confirm absence of signal in knockout strains.

• Recombinant protein controls: Use purified recombinant YDR179W-A protein as a positive control to verify antibody binding to the intended target.

• Epitope competition assay: Pre-incubate the antibody with excess purified antigen before immunostaining to demonstrate specific blocking of antibody binding.

• Cross-reactivity assessment: Test the antibody against related yeast proteins to ensure it doesn't cross-react with similar epitopes.

• Multiple detection methods: Confirm specificity using at least two independent techniques (e.g., Western blot and immunofluorescence).

Since this antibody was generated using recombinant Saccharomyces cerevisiae YDR179W-A protein as the immunogen and further purified through antigen-affinity methods, it should demonstrate high specificity for the target protein .

What are the key considerations when optimizing Western blot protocols for YDR179W-A detection?

For optimal detection of YDR179W-A protein by Western blot:

When interpreting results, remember that post-translational modifications may affect protein mobility, potentially resulting in bands at unexpected molecular weights. Additionally, ensure proper sample denaturation under reducing conditions to fully expose the epitope recognized by this antibody .

Why might I observe inconsistent results in immunofluorescence experiments with YDR179W-A antibody?

Inconsistent immunofluorescence results with YDR179W-A antibody may stem from several methodological factors:

• Fixation method incompatibility: Different fixation protocols (paraformaldehyde vs. methanol) can affect epitope accessibility. Systematically test multiple fixation methods to determine which best preserves the YDR179W-A epitope.

• Permeabilization issues: Insufficient cell wall digestion in yeast cells can prevent antibody penetration. Consider optimizing zymolyase treatment time (typically 30-60 minutes) or using stronger permeabilization agents.

• Antibody concentration: Suboptimal antibody dilution can result in either weak signals or high background. Perform a dilution series (1:100 to 1:1000) to identify the optimal concentration.

• Signal amplification requirements: Low-abundance proteins may require signal amplification systems such as tyramide signal amplification (TSA) or use of highly-sensitive fluorophores.

• Autofluorescence interference: Yeast cells can exhibit significant autofluorescence, particularly in certain media conditions. Include unstained controls and consider using fluorophores that emit at wavelengths distinct from autofluorescence spectra.

Remember that while this antibody has been validated for Western blot and ELISA applications, additional optimization may be required for immunofluorescence studies .

What strategies can improve co-immunoprecipitation efficiency when using YDR179W-A antibody?

To enhance co-immunoprecipitation (Co-IP) efficiency with YDR179W-A antibody:

• Crosslinking optimization: For transient protein-protein interactions, employ reversible crosslinkers like DSP (dithiobis[succinimidyl propionate]) at 0.5-2 mM for 30 minutes at room temperature.

• Lysis buffer selection: Use gentle, non-denaturing buffers (e.g., 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate) supplemented with protease and phosphatase inhibitors.

• Pre-clearing strategy: Pre-clear lysates with protein A/G beads for 1 hour at 4°C to reduce non-specific binding before adding the YDR179W-A antibody.

• Antibody coupling: Consider covalently coupling the antibody to protein A/G beads using dimethyl pimelimidate (DMP) to prevent antibody co-elution in the final sample.

• Extended incubation: Allow antibody-lysate binding to proceed overnight at 4°C with gentle rotation to maximize antigen capture.

• Washing stringency balance: Perform 4-5 washes with progressively lower salt concentrations to remove non-specific binders while preserving specific interactions.

The antigen-affinity purification of this YDR179W-A antibody should provide high specificity for immunoprecipitation applications, though specific conditions may need optimization for your particular experimental system .

How can I utilize YDR179W-A antibody in chromatin immunoprecipitation (ChIP) experiments?

Adapting YDR179W-A antibody for chromatin immunoprecipitation requires specialized optimization:

• Crosslinking protocol: For yeast cells, use 1% formaldehyde for 15-20 minutes at room temperature, followed by quenching with 125 mM glycine for 5 minutes.

• Chromatin fragmentation: Optimize sonication conditions to generate DNA fragments of 200-500 bp (typically 10-15 cycles of 30 seconds on/30 seconds off at medium power).

• Antibody specificity verification: Before proceeding with full ChIP-seq experiments, perform ChIP-qPCR on regions predicted to contain or lack YDR179W-A binding to confirm specificity.

• Input normalization: Always process a small aliquot (5-10%) of pre-immunoprecipitation chromatin as "input" control for normalization.

• Negative controls: Include IgG control immunoprecipitations and, ideally, samples from YDR179W-A deletion strains to establish background signal levels.

• Sequential ChIP consideration: For studying co-occupancy with other proteins, consider sequential ChIP protocols where the chromatin is immunoprecipitated first with YDR179W-A antibody, then with an antibody against the second protein of interest.

While this antibody was not specifically developed for ChIP applications, its polyclonal nature and antigen-affinity purification suggest potential utility in chromatin-related studies after proper validation .

What considerations are important when using YDR179W-A antibody for quantitative proteomics studies?

For integrating YDR179W-A antibody into quantitative proteomics workflows:

• Immunoaffinity enrichment: When using the antibody for enrichment prior to MS analysis, consider gentle elution methods (such as competitive elution with excess antigen peptide) to maintain protein complex integrity.

• Peptide interference: Be aware that the presence of antibody-derived peptides in the sample can complicate mass spectrometry analysis; consider using antibodies covalently linked to beads to minimize contamination.

• Epitope masking: In protein complexes, the YDR179W-A epitope may be partially masked, potentially reducing immunoprecipitation efficiency for certain interaction partners.

• Quantification controls: Include internal standards (isotopically labeled peptides) corresponding to YDR179W-A for accurate quantification.

• Technical replication: Due to variability in immunoprecipitation efficiency, include at least 3-4 technical replicates per experimental condition.

• Validation by orthogonal methods: Confirm key mass spectrometry findings using targeted approaches such as PRM (Parallel Reaction Monitoring) or Western blotting.

The high specificity of this antibody, derived from its development against recombinant protein and subsequent affinity purification, makes it potentially valuable for proteomics applications, though specific validation for this purpose would be required .

How does polyclonal YDR179W-A antibody performance compare to monoclonal alternatives?

The antigen-affinity purification of this polyclonal YDR179W-A antibody helps mitigate some common limitations of polyclonal antibodies by enriching for antibodies that specifically recognize the target antigen, potentially offering a good balance between sensitivity and specificity .

What are the key differences in experimental design when using YDR179W-A antibody across different yeast species?

When adapting YDR179W-A antibody protocols across yeast species:

• Sequence homology considerations: Verify sequence conservation of the target epitope in non-Saccharomyces species. This antibody was raised against S. cerevisiae strain S288c protein, and epitope conservation will directly impact cross-reactivity.

• Cell wall composition differences: Adjust cell lysis protocols based on species-specific cell wall characteristics:

  • S. cerevisiae: Standard zymolyase treatment (30-40 units/ml, 30 minutes)

  • S. pombe: Higher zymolyase concentration (60-80 units/ml) or addition of glucanases

  • C. albicans: Extended treatment times and potential need for additional chitinase enzymes

• Expression level variations: Account for potential differences in YDR179W-A homolog expression levels across species by adjusting protein loading amounts and antibody concentrations.

• Background mitigation: For species with higher non-specific binding profiles, implement more stringent blocking (5% BSA instead of 3%) and washing conditions (increased salt concentration in wash buffers).

• Protein size variations: Be aware that homologs in different species may have different molecular weights, requiring adjustment of electrophoresis and blotting conditions.

Since this antibody was specifically developed against S. cerevisiae YDR179W-A, validation experiments are especially important when applying it to other yeast species to confirm cross-reactivity and specificity .